Clinical Trial Update: Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the safety and cognitive/memory effects of intranasal insulin glulisine in patients with mild-to-moderate Alzheimer's d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Insulin glulisine (insulin glulisine)

Snippet

Sponsor: HealthPartners Institute | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2015-10-19